News

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference (AAIC) in Boston, Mass. While the primary study outcomes were negative, observations from the subgroup analyses include whether there may be a dose-dependent reduction of beta amyloid in the blood and brain of IVIG-treated Alzheimer's patients who have the ApoE4 genotype.

Smokers who've received a clean bill of health from their doctor may believe cigarettes haven't harmed their lungs. However, researchers at Weill Cornell Medical College have found that even smokers who seem healthy have damaged airway cells, with characteristics similar to cells found in aggressive lung cancer.

Patients need to understand their medical conditions in order for them to take an active role in their health care, experts say. Asking their doctors questions is a key -- but frequently challenging -- part of this process, according to a recent Journal of the American Medical Association article.

Awards, honors, prizes and achievements for the week of July 5 - July 12.

Dr. Halinder Mangat, assistant professor of neurology and assistant professor of neurology in neurological surgery at Weill Cornell Medical College, traveled to Mwanza this spring as part of an exchange program between Weill Cornell Medical College and Weill Bugando University College of Health Sciences.

With tens of thousands of Americans diagnosed with brain cancer every year, it is more important than ever to devise new and more effective treatments that will better treat or even cure the disease, experts say. That's why nearly 175 of the nation's leading brain tumor and biotech industry experts assembled at Weill Cornell Medical College June 7 for the second annual Brain Tumor Biotech Summit.

Awards, honors, prizes and achievements for the week of June 28 - July 5.

A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).

Dr. Samie Jaffrey, professor of pharmacology at Weill Cornell, has won a Blavatnik Award for Young Scientists from the New York Academy of Sciences.

The Weill Cornell Medical College community recognized four of its members June 17 for their outstanding service and leadership in promoting diversity at the Medical College.

Fear of malpractice is frequently mentioned as a cause of excessive health care spending. The theory is that to avoid being sued, physicians may practice "defensive medicine" -- ordering tests, procedures and referrals that may not be medically necessary.

Based on the experience of a large hospital in Tanzania, Weill Cornell Medical College researchers have discovered a "startlingly" high burden of hypertension in this sub-Saharan African country.

Two of Weill Cornell Medical College's medical students have earned coveted spots in the Howard Hughes Medical Institute's Medical Research Fellows Program

Dr. Laurie Glimcher speaks with Dr. Mohamed Al-Kazaz, a recent graduate of Weill Cornell Medical College in Qatar and a resident in internal medicine at Weill Cornell and NewYork-Presbyterian Hospital.

The 9/11 attacks on America appear to have caused about one million former smokers across the country to take up the habit again and maintain it, according to a Weill Cornell Medical College public health study.

An international team of investigators co-led by Weill Cornell Medical College is offering a new framework for evidence-based surgery and device research, similar to the kind of risk and benefit analysis used in evidence-based medicine.

A champion for affordable and quality health care around the globe, Chelsea Clinton visited Weill Cornell Medical College May 22 to share the achievements of the Clinton Health Access Initiative.

Dr. Laurie H. Glimcher is elected to the New York Blood Center Board of Trustees and other awards, honors, prizes and achievements for the week of May 31 - June 7.

The Headstrong Project, working in collaboration with Weill Cornell's Department of Public Health, offers free and confidential treatment for Afghanistan and Iraq veterans with PTSD from metropolitan New York and the Tri-State area.

Changes in an epigenetic mechanism that turns expression of genes on and off may be as important as genetic alterations in causing pediatric acute lymphoblastic leukemia (ALL), according to a study led by scientists at St. Jude Children's Research Hospital and Weill Cornell Medical College and published in the June 10 online edition of the Journal of Clinical Investigation.